HitGen's Series B Round

HitGen raised a round of funding on May 28, 2018.

HitGen (先导药物) is a biotech company based in Chengdu, China that specializes in drug discovery and development base on its core platform DNA Encoded Library.…

Articles about HitGen's Series B Round: